Novel development in extraintestinal manifestations and spondylarthropathy

Best Practice and Research: Clinical Gastroenterology

Volumn 25, Issue SUPPL. 1, 2011, Pages

  De Vos, M ^a   Hindryckx, P ^a   Laukens, D ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Crohn's disease; Spondylarthropathy

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD8ALPHA ANTIGEN; CHEMOKINE RECEPTOR CCR9; GAMMA INTERFERON; HLA B27 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; MITOGEN ACTIVATED PROTEIN KINASE 9; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; TUMOR NECROSIS FACTOR ALPHA;

ARTHRITIS; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM STRESS; ENTERITIS; GENE LOCUS; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; INTESTINE EPITHELIUM CELL; NATURAL KILLER T CELL; NONHUMAN; PATTERN RECOGNITION; REVIEW; SIGNAL TRANSDUCTION; SPONDYLOARTHROPATHY; TH17 CELL; TRANSGENIC ANIMAL; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

EID: 79958046377     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/S1521-6918(11)70006-3     Document Type: Article

References (41)

1. Madsen KB, Schiottz-Christensen B, Jurik AG. Prognostic significance of magnetic resonance imaging changes of the sacroiliac joints in spondyloarthritis - a followup study. J Rheumatol 2010;37:1718-27.
2. De Vos M, Mielants H, Cuvelier C, Elewaut A, Veys E. Long-term evolution of gut inflammation in patients with spondyloarthropathy. Gastroenterology 1996;110:1696-703. (Pubitemid 26169205)
3. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999;10:387-98. (Pubitemid 29165293)
4. Hindryckx P, Staelens S, Deleye S, Peeters H, Laukens D, De Vos M. Small animal PET-CT as a non-invasive method to evaluate terminal ileal inflammation in a murine model of Crohn's disease. Gastroenterology 2010;138:S-514-5.
5. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990;63:1099-112. (Pubitemid 120034950)
6. van der Paardt M, Crusius JB, de Koning MH, Murillo LS, van de Stadt RJ, Dijkmans BA, et al. CARD15 gene mutations are not associated with ankylosing spondylitis. Genes Immun 2003;4:77-8. (Pubitemid 38967578)
7. Kim TH, Rahman P, Jun JB, Lee HS, Park YW, Im HJ, et al. Analysis of CARD15 polymorphisms in Korean patients with ankylosing spondylitis reveals absence of common variants seen in western populations. J Rheumatol 2004;31:1959-61. (Pubitemid 39336720)
8. Crane AM, Bradbury L, van Heel DA, McGovern DP, Brophy S, Rubin L, et al. Role of NOD2 variants in spondylarthritis. Arthritis Rheum 2002;46:1629-33.
9. D'Amato M. The Crohn's associated NOD2 3020InsC frameshift mutation does not confer susceptibility to ankylosing spondylitis. J Rheumatol 2002;29:2470-1. (Pubitemid 35266049)
10. Ferreiros-Vidal I, Amarelo J, Barros F, Carracedo A, Gomez-Reino JJ, Gonzalez A. Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's disease. J Rheumatol 2003;30:102-4. (Pubitemid 36077779)
11. Laukens D, Peeters H, Marichal D, Vander Cruyssen B, Mielants H, Elewaut D, et al. CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease. Ann Rheum Dis 2005;64:930-5. (Pubitemid 40733921)
12. Miceli-Richard C, Zouali H, Lesage S, Thomas G, Hugot JP, Said-Nahal R, et al. CARD15/NOD2 analyses in spondylarthropathy. Arthritis Rheum 2002;46:1405-6. (Pubitemid 34525851)
13. Ospelt C, Brentano F, Jungel A, Rengel Y, Kolling C, Michel BA, et al. Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2009;60:355-63.
14. Rosenzweig HL, Jann MJ, Vance EE, Planck SR, Rosenbaum JT, Davey MP. Nucleotide-binding oligomerization domain 2 and Toll-like receptor 2 function independently in a murine model of arthritis triggered by intraarticular peptidoglycan. Arthritis Rheum 2010;62:1051-9.
15. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40:955-62.
16. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008;28:29-39.
17. Rahman P, Inman RD, Gladman DD, Reeve J, Wang N, Peddle L, et al. Association of IL-23R variants and ankylosing spondylitis (AS). Ann Rheum Dis 2007;66:83.
18. Reveille JD, Zhou X, Bradbury LA, Cardon LR, Davis JC, Deloukas P, et al. IL-23R is a major determinant of ankylosing spondylitis risk - the TASC study. Ann Rheum Dis 2007;66:112.
19. Ciccia F, Bombardieri M, Principato A, Giardina A, Tripodo C, Porcasi R, et al. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum 2009;60:955-65.
20. Seiderer J, Elben I, Diegelmann J, Glas J, Stallhofer J, Tillack C, et al. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 2008;14:437-45. (Pubitemid 351571823)
21. Leppkes M, Becker C, Ivanov II, Hirth S, Wirtz S, Neufert C, et al. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 2009;136:257-67.
22. Yang XO, Chang SH, Park H, Nurieva R, Shah B, Acero L, et al. Regulation of inflammatory responses by IL-17F. J Exp Med 2008;205:1063-75. (Pubitemid 351679682)
23. DeLay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum 2009;60:2633-43.
24. Turner MJ, Sowders DP, DeLay ML, Mohapatra R, Bai S, Smith JA, et al. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J Immunol 2005;175:2438-48. (Pubitemid 41113854)
25. Smith JA, Turner MJ, DeLay ML, Klenk EI, Sowders DP, Colbert RA. Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-beta induction via X-box binding protein 1. Eur J Immunol 2008;38:1194-203.
26. Kaser A, Lee AH, Franke A, Glickman JN, Zeissig S, Tilg H, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 2008;134:743-56.
27. Laukens D, Peeters H, Waeytens A, Bogaert S, Vander Cruyssen B, Elewaut D, et al. Reduced metallothionein expression in colonic Crohn's disease: evidence for a new disease-modifying gene. Gastroenterology 2008;134:A-457.
28. Guo R, Ma H, Gao F, Zhong L, Ren J. Metallothionein alleviates oxidative stress-induced endoplasmic reticulum stress and myocardial dysfunction. J Mol Cell Cardiol 2009;47:228-37.
29. Xu J, Wang G, Wang Y, Liu Q, Xu W, Tan Y, et al. Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection. J Cell Mol Med 2009;13:1499-512.
30. Ceylan-Isik AF, Zhao P, Zhang B, Xiao X, Su G, Ren J. Cardiac overexpression of metallothionein rescues cardiac contractile dysfunction and endoplasmic reticulum stress but not autophagy in sepsis. J Mol Cell Cardiol 2009;48:367-78.
31. Cantero-Recasens G, Fandos C, Rubio-Moscardo F, Valverde MA, Vicente R. The asthma-associated ORMDL3 gene product regulates endoplasmic reticulum-mediated calcium signaling and cellular stress. Hum Mol Genet 2010;19:111-21.
32. Laukens D, Georges M, Libioulle C, Sandor C, Mni M, Vander Cruyssen B, et al. Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis. PLos ONE 2010, accepted for publication.
33. Taylor CT, Colgan SP. Hypoxia and gastrointestinal disease. J Mol Med 2007;85:1295-300. (Pubitemid 50004090)
34. Semenza GL. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 2009;24:97-106.
35. Hindryckx P, De Vos M, Jacques P, Ferdinande L, Peeters H, Olievier K, et al. Hydroxylase inhibition abrogates TNF-α-induced intestinal epithelial damage by HIF-1-dependent repression of Fas-associated death domain J Immunol 2010, accepted for publication.
36. Thoms BL, Murphy CL. Inhibition of hypoxia-inducible factor-targeting prolyl hydroxylase domain-containing protein 2 (PHD2) enhances matrix synthesis by human chondrocytes. J Biol Chem 2010;285:20472-80.
37. Apostolaki M, Manoloukos M, Roulis M, Wurbel MA, Muller W, Papadakis KA, et al. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease. Gastroenterology 2008;134:2025-35. (Pubitemid 351790742)
38. Armaka M, Apostolaki M, Jacques P, Kontoyiannis DL, Elewaut D, Kollias G. Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J Exp Med 2008;205:331-7. (Pubitemid 351281599)
39. Jacques P, Venken K, Van Beneden K, Hammad H, Seeuws S, Drennan MB, et al. Invariant natural killer T cells are natural regulators of murine spondylarthritis. Arthritis Rheum 2010;62:988-99.
40. Elewaut D, De Keyser F, Van Den Bosch F, Lazarovits AI, De Vos M, Cuvelier C, et al. Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis. J Rheumatol 1998;25:1932-7. (Pubitemid 28459306)
41. Kontoyiannis D, Boulougouris G, Manoloukos M, Armaka M, Apostolaki M, Pizarro T, et al. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. J Exp Med 2002;196:1563-74. (Pubitemid 36026468)